72 unknown. 72 Phase 3, 20 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 72 | Unknown 72 |
| Phase 2 | 20 | Unknown 20 |
Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2 Dexamethasone - Covid19, Dexamethasone | Phase 3 | Unknown | Hospital Universitario Infanta Leonor | 200 | 2023-02-28 | 2023-03-01 |
| Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19 Nitazoxanide, Placebo - covid19 | Phase 3 | Unknown | Azidus Brasil | 380 | 2022-06-22 | 2022-10-31 |
| The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients Sitagliptin - Covid19, Diabetes Mellitus, Type 2 | Phase 3 | Unknown | University of Milan | 170 | 2021-12-29 | 2021-09-28 |
| Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen] Ivermectin, Placebo - Covid19 | Phase 3 | Unknown | Infectopharm Arzneimittel GmbH | 412 | 2021-11-01 | 2021-11-02 |
| Novaferon in Non-hospitalized Adult Patients With Mild COVID-19 Novaferon, Placebo - Covid19 | Phase 3 | Unknown | Genova Inc. | 222 | 2021-10-28 | 2022-03-03 |
| Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19 Baricitinib, Placebo - Covid19 | Phase 3 | Unknown | Incepta Pharmaceuticals Ltd | 480 | 2021-10-01 | 2021-09-28 |
| FLuticasone in cOvid Treatment (FLOT) Fluticasone Propionate - Covid19 | Phase 2 / Phase 3 | Unknown | University of Medicine and Pharmacy at Ho Chi Minh City | 500 | 2021-09-22 | 2021-09-23 |
| High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial. High doses of intravenous vitamin C, Dextrose 500 mL - Covid19 | Phase 3 | Unknown | Hugo Galindo | 160 | 2021-09-15 | 2021-08-31 |
| Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt Astrazenica vaccine - Covid19 | Phase 3 | Unknown | Samia Hassan El-Shishtawy | 200 | 2021-08-30 | 2021-09-02 |
| Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19 Andrographis Paniculata, Boesenbergia, Standard supportive treatment - Covid19 | Phase 3 | Unknown | Mahidol University | 3060 | 2021-08-30 | 2021-09-09 |
| TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 Peginterferon Lambda-1A, Placebo - Sars-CoV2, Covid19 | Phase 3 | Unknown | University Health Network, Toronto | 763 | 2021-08-27 | 2022-04-05 |
| Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT Atorvastatin 40 Mg Oral Tablet, Placebo - Covid19, SARS-CoV2 Infection | Phase 3 | Unknown | Mansoura University | 220 | 2021-08-14 | 2021-10-25 |
| Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19 to be given as a treatment - Covid19 | Phase 3 | Unknown | Salmaniya Medical Complex | 500 | 2021-08-05 | 2021-08-19 |
| Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) - Covid19 | Phase 2 / Phase 3 | Unknown | Dow University of Health Sciences | 310 | 2021-08-01 | 2022-10-17 |
| Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized) Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment, Isotretinoin (13 cis retinoic acid ) capsules - COVID19 | Phase 3 | Unknown | Kafrelsheikh University | 100000 | 2021-08-01 | 2021-08-05 |
| Urine Alkalinisation to Prevent AKI in COVID-19 Sodium Bicarbonate 150Meq/L/D5W Inj - Covid19 | Phase 3 | Unknown | Guy's and St Thomas' NHS Foundation Trust | 80 | 2021-07-19 | 2022-03-15 |
| Study of Gam-COVID-Vac in Adolescents Gam-COVID-vac M, Placebo - Covid19, Vaccine Preventable Disease | Phase 2 / Phase 3 | Unknown | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 3000 | 2021-07-05 | 2021-09-16 |
| Ivermectin Versus Standard Treatment in Mild COVID-19 Ivermectin Tablets - Covid19 | Phase 3 | Unknown | Assiut University | 1644 | 2021-07-01 | 2021-06-29 |
| Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 Placebo administration, Confirm SARS-CoV-2 infection, Physical Examination - Corona Virus Infection, Covid19 | Phase 3 | Unknown | MGC Pharmaceuticals d.o.o | 252 | 2021-06-11 | 2022-08-24 |
| Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 Novaferon, Placebo - Covid19 | Phase 3 | Unknown | Genova Inc. | 914 | 2021-06-10 | 2022-06-03 |
Showing 20 of 72. Sign in to see all of them.
COVID-19 (72) · Severe Acute Respiratory Syndrome (7) · Coronavirus Infections (6) · Acute Kidney Injury (1) · Alzheimer Disease 5 (1) · Communicable Diseases (1) · Critical Illness (1) · Diabetes Mellitus, Type 2 (1) · Frailty (1) · Hemostatic Disorders (1) · Inflammation (1) · Pneumonia, Viral (1) · Respiratory Tract Infections (1) · Thrombosis (1) · Thrombotic Microangiopathies (1)
Coronaviridae Infections (72) · Infections (72) · Lung Diseases (72) · Nidovirales Infections (72) · Pneumonia (72) · RNA Virus Infections (72) · Respiratory Tract Diseases (72) · Virus Diseases (72) · Pneumonia, Viral (71) · Respiratory Tract Infections (71) · Coronavirus Infections (66) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Cardiovascular Diseases (2) · Disease Attributes (2)
Standard of Care (6) · Hydroxychloroquine (5) · Ivermectin (5) · Atorvastatin (4) · remdesivir (4) · tocilizumab (4) · Dexamethasone (3) · Gam-COVID-Vac vaccine (3) · Tablets (3) · baricitinib (3) · favipiravir (3) · recombinant interferon alpha 2b-like protein (3) · Azithromycin (2) · Fluoxetine (2) · Folic Acid (2)
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (4) · Genova Inc. (3) · Lebanese American University Medical Center (2) · ANRS, Emerging Infectious Diseases (1) · ASST Fatebenefratelli Sacco (1) · Abderrahmane Mami Hospital (1) · Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran (1) · Ain Shams University (1) · Assistance Publique - Hôpitaux de Paris (1) · Assistance Publique Hopitaux De Marseille (1) · Assiut University (1) · Azidus Brasil (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Bharat Biotech International Limited (1) · Biomed Industries, Inc. (1)
Egypt (7) · Italy (6) · Pakistan (4) · Bangladesh (3) · Brazil (3) · Canada (3) · Colombia (3) · Argentina (2) · France (2) · India (2) · Indonesia (2) · Japan (2) · Lebanon (2) · Philippines (2) · Tunisia (2)
Ahmad Imran, MBBS (1) · Ahmed Cordie, lecturer (1) · Akter Kamal, MD, PhD (1) · Aliae AR Mohamed-Hussein, MD (1) · Anna Vlasova (1) · Aydin Erenmemisoglu, Prof.Dr. (1) · Belen L Dofitas, MD, PhD (1) · Ben WJ Mol, MD (1) · Charlotte Summers (1) · Dante S Harbuwono, MD, PhD (1) · Dr Anjan Jyoti Talukdar (1) · Dr Azhar Ali Khan (1)
PMID 32171076, PMID 34473343, PMID 35244208, PMID 36700518, PMID 37489818, PMID 11594901, PMID 25822153, PMID 26752081, PMID 27550352, PMID 30536180, PMID 32109013, PMID 32142651, PMID 32150748, PMID 32187464, PMID 32497319, PMID 33065103, PMID 33227231, PMID 33502773, PMID 34163159, PMID 34350582, PMID 34526081, PMID 34717820, PMID 34774196, PMID 34927127, PMID 35353979, PMID 35941669, PMID 36160152, PMID 36348476, PMID 36516104, PMID 36574985, PMID 36695483, PMID 36780676, PMID 37068273, PMID 37256990, PMID 37600800, PMID 38389078, PMID 39232602, PMID 39339956